Helicobacter pylori News and Research

RSS
Study finds above-average rates of mortality from gastric cancer in South Florida

Study finds above-average rates of mortality from gastric cancer in South Florida

Combination of three technologies makes potential treatment effective against aggressive brain tumor

Combination of three technologies makes potential treatment effective against aggressive brain tumor

Study confirms accuracy of new generation GastroPanel® test

Study confirms accuracy of new generation GastroPanel® test

Researchers identify five types of bacteria in men with aggressive prostate cancer

Researchers identify five types of bacteria in men with aggressive prostate cancer

New study reveals oral opaganib's potent in vitro activity against Omicron

New study reveals oral opaganib's potent in vitro activity against Omicron

Self-assembling SARS-CoV-2 spike protein-directed nanoparticle vaccines

Self-assembling SARS-CoV-2 spike protein-directed nanoparticle vaccines

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

Study analyzes the resistance of H. pylori bacterium to antibiotics

Study analyzes the resistance of H. pylori bacterium to antibiotics

New imaging technology for detecting MALT lymphomas could save patients numerous gastroscopies

New imaging technology for detecting MALT lymphomas could save patients numerous gastroscopies

Researchers identify eight primary factors that increase GI bleeding risk after heart attack

Researchers identify eight primary factors that increase GI bleeding risk after heart attack

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

Irritable bowel syndrome is linked to bacterial biofilms in the gut

Irritable bowel syndrome is linked to bacterial biofilms in the gut

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

A SARS-CoV-2 ferritin nanoparticle vaccine elicits broad immunity

A SARS-CoV-2 ferritin nanoparticle vaccine elicits broad immunity

Host protein mimicry of SARS-CoV-2 receptor binding motif

Host protein mimicry of SARS-CoV-2 receptor binding motif

Cholestenone could be a new antibacterial drug against H. pylori

Cholestenone could be a new antibacterial drug against H. pylori

Study finds a bacterial molecule that may be key to fighting gastric cancer

Study finds a bacterial molecule that may be key to fighting gastric cancer

Asymptomatic SARS-CoV-2 individuals with blood group AB at highest risk

Asymptomatic SARS-CoV-2 individuals with blood group AB at highest risk